Stay updated on rollout timelines and eligibility to maximize savings
The main federal Wegovy litigation remains focused on gastrointestinal injuries, while NAION-related allegations should be evaluated separately based on medical records, diagnosis, timing, and prescribing history
Osborne has now turned to a non-FDA approved, discounted version of the drug from out of state
It also describes recent changes to the administrations plans for temporary coverage of GLP-1s in Medicare, including an indefinite delay in implementation of the BALANCE Model in Part D and an extension of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
BPC-157, however, remains intact in gastric juice and retains its biological activity after oral administration
Education level might also be critical to the awareness of long-term obesity implications 110